2m 2m 2m 2m 2m 2m 2m
ERNEXA THERAPE (ERNA)
NASDAQ
$2.10+$0.02 (+0.96%)
Price as of Oct 22, 2026 7:30 PM EDT- $2.5MMarket Cap
- -92.66%1-Year Change
- BiotechnologyIndustry
ERNEXA THERAPE (ERNA)
$2.10+$0.02 (+0.96%)
ERNA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.08 | ||
Change | -$0.13 (-5.80%) | ||
Open | $2.10 | ||
High | $2.13 | ||
Low | $1.98 | ||
Previous Close | $2.11 | ||
Volume | 16,467 | ||
30-Day Average Volume | 64,982 | ||
1-Week Change | 0.00% | ||
1-Month Change | -46.72% | ||
1-Year Change | -92.66% | ||
3-Year Change | -99.68% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.2M | ||
Total Assets | $6.3M | ||
Market Cap | $2.5M | ||
Enterprise Value | -$1.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.0M | ||
Free Cash Flow | -$4.2M | ||
EBIT | -$4.0M | ||
EBITDA | -$4.0M | ||
Net Working Capital | $3.0M | ||
EPS | -$3.40 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 05/04/2026 | ||
Earnings & Revenue